Table 2. LncRNA MIR4435-2HG expression associated with clinical pathological characteristics (logistic regression).
| Characteristics | Total (N) | Odds ratio in MIR4435-2HG expression | P-value |
|---|---|---|---|
| T (T1/T2 vs. T3/T4) | 578 | 1.66 (1.11–2.49) | 0.015 |
| N (N0 vs. N1N2) | 577 | 1.68 (1.2–2.34) | 0.002 |
| M (M0 vs. M1) | 515 | 1.54 (0.96–2.49) | 0.077 |
| Stage (Stage 1/2 vs. Stage 3/4) | 560 | 1.66 (1.19–2.32) | 0.003 |
| CEA level before treatment (<5 vs. =>5) | 375 | 1.7 (1.11–2.6) | 0.015 |
| Colon polyps (No vs. Yes) | 286 | 1.08 (0.65–1.8) | 0.766 |
| History of colon polyps (No vs. Yes) | 495 | 1.19 (0.82–1.75) | 0.360 |
| Histological type (Colon cancer vs. Rectal cancer) | 580 | 0.82 (0.57–1.19) | 0.304 |
| Perineural invasion (No vs. Yes) | 219 | 1.48 (0.81–2.74) | 0.207 |
| Status (Tumor free vs. With tumor) | 511 | 0.99 (0.7–1.4) | 0.949 |
| Venous invasion (No vs. Yes) | 502 | 1.38 (0.92–2.09) | 0.120 |